PaceLine Consulting
"Go Faster Together"
Terry L. Burkoth, Ph.D.
General Product Development Capabilities & Interests
- Development program design - critical
review
- Problem-solving - idea-generation
- Presentation critical review or drafting
- Regulatory submission review, editing, drafting
- Test data review (non-statistical)
- Pre-investment technical due diligence
- Drug delivery design
- Form & formulation
- ADMET study design
- Safety study design
- FMEA (failure mode and effect analysis)
- New molecular entity development planning
Contact:
terry@burkoth.com
Burkoth Experience (>35 years):
- TheraJect Inc., Board Member and Acting CEO, a start-up company seeking funds to develop rapidly dissolving micro-needle patches for delivery of traditional, protein and polynucleotide drugs and vaccines TheraJect
- PowderChek Inc., Co-founder,
Chairman & CTO, a start-up company seeking funds to develop a powder-injection-based
continuous glucose self diagnostic technology for diabetics
- PowderJect Pharmaceuticals plc,
Senior Vice President, Science & Technology, Founding Board Member PJP
- ALZA Corporation, Vice President,
Product Development, Principal Scientist ALZA
- Sandoz-Zoecon, Vice President,
Product Development, guiding five novel chemicals from lab discovery to commercial
products
- Syva Corporation-Synvar Research
Institute, Scientist-Manager, basic photochemical research and early development
of novel diagnostics
- AB (chemistry) Ripon College,
PhD (organic chemistry) Stanford University, NIH Postdoctoral Fellow Columbia
University, Academic Visitor Oxford University